| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |